DEXTROSE 25% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dextrose 25%, and when can generic versions of Dextrose 25% launch?
Dextrose 25% is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in DEXTROSE 25% is dextrose. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextrose profile page.
Summary for DEXTROSE 25%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 16 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXTROSE 25% at DailyMed |
US Patents and Regulatory Information for DEXTROSE 25%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | DEXTROSE 25% | dextrose | INJECTABLE;INJECTION | 019445-002 | Nov 23, 1998 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |